Filing Flows

Filing Flows › Exponent (EXPO) › Guidance & outlook

Exponent (EXPO) guidance and outlook

Exponent (EXPO) raised its guidance on Oct 29, 2026: Revenue +8% to +10% for Q4 FY2026; Revenue +10% to +11% for FY2026. Exponent's 10-Q filed Nov 6, 2026 makes 8 forward-looking statements.

Guidance and outlook

Exponent: what its forward-looking statements are about (10-Q filed 2026-11-06)Exponent: what its forward-looking statements are about (10-Q filed 2026-11-06)Costs4Other3Capital spending1
8 statements; tone +0.62 (−1 all cautious, +1 all confident); 1 hedged.
Exponent: outlook statements against the filing beforeExponent: outlook statements against the filing beforeConfident5

Latest guidance

MetricPeriodRangeChange
RevenueQ4 FY2026+8% to +10%new
RevenueFY2026+10% to +11%new

From the earnings release filed Oct 29, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 6, 2026

Exponent's latest quarter

Exponent, Q3 2026: revenue $174M (+18% year over year), operating margin 24.1%, net earnings $30.9M, operating cash flow $63.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did Exponent raise or lower its guidance?

Exponent (EXPO) raised its guidance on Oct 29, 2026: Revenue +8% to +10% for Q4 FY2026; Revenue +10% to +11% for FY2026.

What does Exponent expect?

The increase in revenues for our Engineering and Other Scientific segment was due to an increase in billable hours, an increase in billing rates and an increase in revenues from reimbursements associated with user research projects. We expect other operating expenses to grow as we selectively add new talent and make investments in our corporate infrastructure. The amount of reimbursable expenses will vary from quarter to quarter depending on the nature of our projects.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.